ASIA News

Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population.

Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement.

Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, recently announced that their “Voiceprint Login System” (“Voiceprint Lock”), jointly developed with Unisound, an intelligent voice and language technology company in China, has achieved a login success rate close to 99%.

.

Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.

Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012.

The company announced last week that it had placed its One-minute Clinics across 8 provinces and cities in China and signed service contracts for nearly 1,000 units.

.

.

The company's wearable device collects data and automatically uploads to the cloud, which makes it is easier to use than conventional technology used for the same purpose, says Yun Hong, Global Business Manager, Samsung SDS.